Displaying drugs 2576 - 2600 of 2780 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Tocopherol | Not Available | Tocopherol can be used as a dietary supplement for patients with a deficit of vitamin E; this is mainly prescribed in the alpha form. Vitamin E deficiency is rare, and... | Vitamins | |
Tofacitinib | 312.3696 C16H20N6O | A Janus kinase (JAK) inhibitor used to treat rheumatic conditions, such as rheumatoid arthritis and ankylosing spondylitis, and ulcerative colitis. | Selective Immunosuppressants | |
Tolazamide | 311.4 C14H21N3O3S | A sulfonylurea used in the treatment of non insulin dependent diabetes mellitus. | Sulfonylureas | |
Tolazoline | 160.2157 C10H12N2 | A vasodilator used to treat pulmonary artery anomalies. | Imidazoline Derivatives | |
Tolbutamide | 270.348 C12H18N2O3S | A sulfonylurea used to treat hyperglycemia in patients with type 2 diabetes mellitus. | Tests for Diabetes | |
Tolcapone | 273.2408 C14H11NO5 | A catechol-O-methyltransferase (COMT) inhibitor used as adjunct therapy in the symptomatic management of idiopathic Parkinson's disease. | Anti-Parkinson Drugs | |
Tolevamer | Not Available | A potassium-binding resin used in the treatment of hyperkalemia. | Drugs for Treatment of Hyperkalemia and Hyperphosphatemia | |
Tolfenamic acid | 261.704 C14H12ClNO2 | In the information for tolfenamic acid, it is stated that this drug, being an NSAID, is effective in treating the pain associated with the acute attack of migraines in adults. | Fenamates | |
Tolmetin | 257.2845 C15H15NO3 | An NSAID used to treat acute flares of various painful conditions and used for the long term management of osteoarthritis, rheumatoid arthritis, and juvenile arthritis. | Acetic Acid Derivatives and Related Substances / Antiinflammatory Preparations, Non-Steroids for Topical Use | |
Tolnaftate | 307.409 C19H17NOS | An antifungal agent used to treat various skin infections caused by fungi. | Antifungal Agents / Naphthalenes / Thiocarbamates | |
Tolterodine | 325.4876 C22H31NO | A muscarinic receptor antagonist used to treat overactive bladder with urinary incontinence, urgency, and frequency. | Drugs for Urinary Frequency and Incontinence | |
Tolvaptan | 448.941 C26H25ClN2O3 | A selective vasopressin V2-receptor antagonist to slow kidney function decline in patients at risk for rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). Also used to treat hypervolemic and euvolemic hyponatremia. | Antidiuretic Hormone Receptor Antagonists / Benzazepines / Vasopressin V2 Receptor Antagonist | |
Topiramate | 339.362 C12H21NO8S | An anticonvulsant drug used in the control of epilepsy and in the prophylaxis and treatment of migraines. | Centrally Acting Antiobesity Products | |
Topotecan | 421.4458 C23H23N3O5 | An antineoplastic agent used to treat ovarian cancer, small cell lung cancer, or cervical cancer. | Topoisomerase 1 (TOP1) inhibitors | |
Torasemide | 348.42 C16H20N4O3S | A diuretic used to treat hypertension and edema associated with heart failure, renal failure, or liver disease. | Sulfonamides | |
Toremifene | 405.96 C26H28ClNO | A first generation nonsteroidal selective estrogen receptor modulator used to treat certain breast cancers. | Anti-Estrogens | |
Tovorafenib | 506.29 C17H12Cl2F3N7O2S | A type II RAF inhibitor used to treat pediatric low-grade glioma with BRAF gene mutations. | B-Raf serine-threonine kinase (BRAF) inhibitors / BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP1A2 Inducers / Cytochrome P-450 CYP1A2 Inducers (strength unknown) / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Heterocyclic Compounds, Fused-Ring / Sulfur Compounds | |
Trabectedin | 761.837 C39H43N3O11S | An alkylating agent approved for the treatment of unresectable or metastatic soft tissue sarcoma (liposarcoma or leiomyosarcoma). | Alkylating Drugs / Antineoplastic Agents, Alkylating / Dioxoles / Tetrahydroisoquinolines | |
Tramadol | 263.381 C16H25NO2 | A centrally-acting opioid agonist and SNRI (serotonin/norepinephrine reuptake inhibitor) used for the management of moderate to severe pain in adults. | Agents producing tachycardia / Agents that reduce seizure threshold / Analgesics / Opioids | |
Trametinib | 615.3948 C26H23FIN5O4 | A kinase inhibitor used alone or in combination with dabrafenib to treat patients with cancers with specific BRAF mutations, such as melanoma and non-small cell lung cancer. | Mitogen-activated protein kinase (MEK) inhibitors / Protein Kinase Inhibitors | |
Trandolapril | 430.5372 C24H34N2O5 | A prodrug of an ACE inhibitor used to treat hypertension, congestive heart failure, and to improve survival following a myocardial infarction. | ACE Inhibitors and Calcium Channel Blockers | |
Tranexamic acid | 157.2102 C8H15NO2 | An antifibrinolytic used to reduce or prevent hemorrhagic episodes, especially in the context of hyperfibrinolytic disorders. | Amino Acids | |
Tranylcypromine | 133.194 C9H11N | A monoamine oxidase inhibitor used to treat major depressive disorder. | Monoamine Oxidase Inhibitors, Non-Selective | |
Travoprost | 500.5477 C26H35F3O6 | A prostaglandin analog used in the treatment of elevated intraocular pressure due to open angle glaucoma or ocular hypertension. | Antihypertensive Agents / Prostaglandins, Synthetic | |
Trazodone | 371.864 C19H22ClN5O | A serotonin uptake inhibitor used to treat major depressive disorder. | Agents that produce hypertension |
Displaying drugs 2576 - 2600 of 2780 in total